Alpha-lipoic acid (ALA) is a powerful antioxidant that plays an important role in metabolism, weight management, and brain health. Research shows it may improve insulin sensitivity, support healthy blood sugar regulation, promote fat metabolism, and help protect against cognitive decline by reducing oxidative stress and improving mitochondrial function. For patients focused on longevity and prevention, ALA may represent one of the most versatile evidence-based nutritional int

Visceral fat is not merely stored energy—it is a biologically active tissue that drives insulin resistance, cardiovascular disease, cognitive decline, and accelerated aging. Many individuals with normal weight harbor excess visceral fat. Identifying and reducing it early can dramatically improve metabolic health and long-term healthspan.

Metabolic dysfunction–associated steatotic liver disease (MASLD), formerly called fatty liver, is not a liver problem alone—it is a systemic marker of insulin resistance. Often silent for years, MASLD signals elevated cardiometabolic, cognitive, and longevity risk long before abnormal liver enzymes or diabetes appear.

Insulin resistance often develops years before diabetes, heart disease, or dementia are diagnosed. During this silent phase, metabolic dysfunction damages blood vessels, the brain, and cellular aging pathways. Understanding insulin resistance early allows for targeted intervention that can meaningfully reduce cardiovascular risk, cognitive decline, and accelerated biological aging.